Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

Delayed Quote. Delayed  - 05/27 09:59:59 pm
1.73 USD   +1.76%
05/25 GALENA BIOPHARM : to Present at the Sachs Associates 2nd Annual Immu..
05/24 Galena Biopharma to Present at the Sachs Associates 2nd Annual Im..
05/20 GALENA BIOPHARM : to Present GALE-401 Combined Safety Data at the Eu..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
1.67(c) 1.74(c) 1.72(c) 1.7(c) 1.73(c) Last
3 350 255 3 709 510 3 071 655 2 257 382 973 320 Volume
+9.87% +4.19% -1.15% -1.16% +1.76% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -38,4 M
Net income 2016 -52,3 M
Debt 2016 -
Yield 2016 -
Sales 2017 2,50 M
EBIT 2017 -41,0 M
Net income 2017 -44,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 124x
Capitalization 309 M
More Financials
Company
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of... 
Sector
Pharmaceuticals
Calendar
06/03Presentation
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
05/25 GALENA BIOPHARMA : to Present at the Sachs Associates 2nd Annual Immuno-Oncology..
05/24 Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncolog..
05/20 GALENA BIOPHARMA INC : 6 Biotech Stocks That Will Heat Up Heading Into The Summe..
05/20 GALENA BIOPHARMA : to Present GALE-401 Combined Safety Data at the European Hema..
05/19 Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hem..
05/18 Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the A..
05/10 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
05/10 GALENA BIOPHARMA, INC. : Results of Operations and Financial Condition, Regulati..
05/10 GALENA BIOPHARMA : reports 1Q loss
05/10 Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a ..
More news
Sector news : Pharmaceuticals - NEC
10:17p MARKETS RIGHT NOW : Stocks close higher on Wall Street
10:14p DR REDDY LABORATORIES : Merger and Acquisition Round Up – May 23 to 27, 20..
09:53p SANOFI : eyeing manufacturing expansion
08:48p Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
08:47p Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/11 Galena Biopharma's (GALE) CEO Mark Schwartz on Q1 2016 Results - Earnings Cal..
05/09 Notable earnings after Tuesday?s close
04/04 Midday Gainers/ Losers
03/30 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
03/29 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions